Arcellx

Associate Director, Regional Marketing & Thought Leader Liaison

Redwood City, California, United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Associate Director, Regional Marketing & Thought Leader Liaison (TLL)

Employment Type: [Not Specified] Location Type: Field-Based Salary: [Not Specified]

Who We Are

Arcellx is a public, clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. We believe that cell therapies are one of the forward pillars of medicine and our mission is to destroy cancer and advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible.

Our team members are made up of talented innovators and dreamers working from our offices in Rockville, Maryland, and Redwood City, California. At Arcellx, we hire exceptional people and create a fun, diverse, supportive, and informal environment that allows everyone to do their best work.

What Matters to Us

Living our core values is essential to maintaining a work environment that is high-performing, inclusive, and collaborative. We look for candidates who demonstrate strong values alignment and bring different backgrounds, viewpoints, and abilities to the team.

Arcellx Core Values:

  • Start with authenticity: We foster an inclusive environment where each person can bring their authentic self to work.
  • Think ‘we’ before ‘me’: We prioritize collective success, collaborating and supporting one another to achieve our shared goals.
  • Embrace the challenge: We deliver exceptional results by working with shared determination and a commitment to doing what’s right.

How You’ll Make a Difference

We are seeking a highly motivated, field-based marketing leader to join our Commercial team as Associate Director, Regional Marketing & Thought Leader Liaison (TLL). This role will be critical in shaping and executing Arcellx’s thought leader and key customer engagement strategy in the U.S., with a specific focus on supporting the launch and growth of anitocabtagene autoleucel (anito-cel), our lead CAR T candidate for relapsed/refractory multiple myeloma.

This individual will serve as a key interface between Arcellx and regional/national thought leaders, academic centers, and influential community networks. The TLL will act as a bridge between the field and home office teams, generating actionable insights to inform brand strategy, educational initiatives, and speaker engagement efforts. This is a non-sales role that works in close partnership with colleagues across Commercial, Medical Affairs, and Market Access, as well as with Kite Pharma through our co-promotion agreement.

The “Fine Print” – What You’ll Do

  • Identify, engage, and maintain relationships with thought leaders and key customers within the multiple myeloma and CAR T space.
  • Support regional advisory boards, executive encounters, and educational initiatives.
  • Collaborate with cross-functional partners to ensure cohesive external engagement across all customer-facing teams.
  • Capture and synthesize field insights to inform brand planning, promotional messaging, and HCP education efforts.
  • Assist with the development of a national and regional thought leader map, engagement planning, and KOL capabilities assessment.
  • Provide key input into the planning and execution of medical and commercial congress activity, including ASH, ASCO, EHA and IMS.
  • Contribute to the creation of compliant, value-added customer engagement tools and resources.

Skills and Experience We Look For

  • Bachelor’s degree required; advanced degree (PharmD, PhD, MBA) preferred.
  • 8+ years of experience in the biopharmaceutical industry, with at least 3–5 years in hematology/oncology; experience in multiple myeloma or CAR T is strongly preferred. More experienced candidates may be considered at the director level.
  • Prior experience in field marketing, key customer marketing, or thought leader liaison roles is highly desirable.
  • Demonstrated ability to engage credibly and compliantly with academic and community thought leaders.
  • Strong collaboration skills and ability to operate effectively in a matrixed environment.
  • Proven ability to extract, analyze, and communicate field insights.

Skills

Marketing Strategy
Thought Leader Engagement
Customer Engagement
CAR T
Biotechnology
Oncology
Multiple Myeloma
Field Marketing
Commercial Strategy

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Gaithersburg, MarylandHeadquarters
2014Year Founded
$194.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Flexible Work Hours
401(k) Company Match
Fully-Paid Parental Leave
Tuition Reimbursement
Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI